07:00 , Jun 9, 2016 |  BC Innovations  |  Strategy

Sanofi's post-reconstruction era

Lauren Martz, Senior Writer  Five years after taking the helm as Sanofi's president of global R&D, Elias Zerhouni is rounding out his strategy to revamp the division and rebuild the pipeline with the appointment of Yong-Jun...
07:00 , Apr 21, 2014 |  BC Week In Review  |  Clinical News

Regulus preclinical data

In a mouse xenograft model of HCC, thrice-weekly subcutaneous 25 mg/kg anti-microRNA-221 (miR-221) oligonucleotides for 3 weeks significantly inhibited tumor growth vs. vehicle-treated controls (p<0.005). Data were presented at the American Association for Cancer Research...